Comparison of Biophen DiXaI®, Prothrombin Time With a Reference HPLC-MS/MS Method to Monitor Patients Receiving Rivaroxaban

Jonathan Douxfils; Anne Tamigniau; Jean-François Classen; Justine Baudar; Sébastien Walbrecq; Christian Chatelain; Bernard Chatelain; Pierre Wallemacq; François Mullier; Jean-Michel Dogne

Comparison of Biophen DiXaI®, Prothrombin Time With a Reference HPLC-MS/MS Method to Monitor Patients Receiving Rivaroxaban

Jonathan Douxfils, Anne Tamigniau, Jean-François Classen, Justine Baudar, Sébastien Walbrecq, Christian Chatelain, Bernard Chatelain, Pierre Wallemacq, François Mullier, Jean-Michel Dogne

Research output: Contribution to conference › Poster › peer-review

Original language	English
Publication status	Published - 2013
Event	XXIV Congress of the International Society of Thrombosis and Haemostasis - Amsterdam, Netherlands Duration: 29 Jun 2013 → 4 Jul 2013

Conference

Conference	XXIV Congress of the International Society of Thrombosis and Haemostasis
Country/Territory	Netherlands
City	Amsterdam
Period	29/06/13 → 4/07/13

Access to Document

http://www.eventure-online.com/eventure/publicAbstractView.do?id=215953&congressId=6839

Evaluation of thrombotic and/or bleeding risks associated with anticoagulotherapy.
Author: Douxfils, J., 24 Oct 2015
Supervisor: Dogne, J. (Supervisor), Mullier, F. (Supervisor), Masereel, B. (President), Chatelain, B. (Jury), Chatelain, C. (External person) (Jury), Verhamme, P. B. (External person) (Jury), TEN CATE, H. (External person) (Jury) & Ageno, W. (External person) (Jury)
Student thesis: Doc types › Doctor of Biomedical and Pharmaceutical Sciences

Cite this

Douxfils, J., Tamigniau, A., Classen, J.-F., Baudar, J., Walbrecq, S., Chatelain, C., Chatelain, B., Wallemacq, P., Mullier, F., & Dogne, J.-M. (2013). Comparison of Biophen DiXaI®, Prothrombin Time With a Reference HPLC-MS/MS Method to Monitor Patients Receiving Rivaroxaban. Poster session presented at XXIV Congress of the International Society of Thrombosis and Haemostasis, Amsterdam, Netherlands. http://www.eventure-online.com/eventure/publicAbstractView.do?id=215953&congressId=6839

@conference{deac985cf9984bc48f6538ac17a465a0,

title = "Comparison of Biophen DiXaI{\textregistered}, Prothrombin Time With a Reference HPLC-MS/MS Method to Monitor Patients Receiving Rivaroxaban",

author = "Jonathan Douxfils and Anne Tamigniau and Jean-Fran{\c c}ois Classen and Justine Baudar and S{\'e}bastien Walbrecq and Christian Chatelain and Bernard Chatelain and Pierre Wallemacq and Fran{\c c}ois Mullier and Jean-Michel Dogne",

year = "2013",

language = "English",

note = "XXIV Congress of the International Society of Thrombosis and Haemostasis ; Conference date: 29-06-2013 Through 04-07-2013",

}

Douxfils, J, Tamigniau, A, Classen, J-F, Baudar, J, Walbrecq, S, Chatelain, C, Chatelain, B, Wallemacq, P, Mullier, F & Dogne, J-M 2013, 'Comparison of Biophen DiXaI®, Prothrombin Time With a Reference HPLC-MS/MS Method to Monitor Patients Receiving Rivaroxaban', XXIV Congress of the International Society of Thrombosis and Haemostasis, Amsterdam, Netherlands, 29/06/13 - 4/07/13. <http://www.eventure-online.com/eventure/publicAbstractView.do?id=215953&congressId=6839>

Comparison of Biophen DiXaI®, Prothrombin Time With a Reference HPLC-MS/MS Method to Monitor Patients Receiving Rivaroxaban. / Douxfils, Jonathan; Tamigniau, Anne; Classen, Jean-François et al.
2013. Poster session presented at XXIV Congress of the International Society of Thrombosis and Haemostasis, Amsterdam, Netherlands.

Research output: Contribution to conference › Poster › peer-review

TY - CONF

T1 - Comparison of Biophen DiXaI®, Prothrombin Time With a Reference HPLC-MS/MS Method to Monitor Patients Receiving Rivaroxaban

AU - Douxfils, Jonathan

AU - Tamigniau, Anne

AU - Classen, Jean-François

AU - Baudar, Justine

AU - Walbrecq, Sébastien

AU - Chatelain, Christian

AU - Chatelain, Bernard

AU - Wallemacq, Pierre

AU - Mullier, François

AU - Dogne, Jean-Michel

PY - 2013

Y1 - 2013

M3 - Poster

T2 - XXIV Congress of the International Society of Thrombosis and Haemostasis

Y2 - 29 June 2013 through 4 July 2013

ER -

Comparison of Biophen DiXaI®, Prothrombin Time With a Reference HPLC-MS/MS Method to Monitor Patients Receiving Rivaroxaban

Conference

Access to Document

Student theses

Evaluation of thrombotic and/or bleeding risks associated with anticoagulotherapy.

Cite this